Product Information
ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET is a generic product labeled by i3 Pharmaceuticals, LLC, priced at $0.7091 per EA under NDC 72319001203. Its NADAC has been published 124 times since Apr 10, 2024.
FDA first approved this application on Jan 17, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET
isosorbide dinitrate and hydralazine hydrochlorideStrength
37.5; 20 mg/1; mg/1
Manufacturer
i3 Pharmaceuticals, LLCNDC
72319001203
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
HYDRALAZINE HYDROCHLORIDE; ISOSORBIDE DINITRATEApproval Type
Generic (ANDA)
FDA Application
ANDA215988FDA Approved
1/17/2024
TE Code
AB
On Market Since
2/7/2024
Pharmacological Classes
Price Statistics
The NADAC for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET has been published 124 times since Apr 10, 2024, and over the history we have for it it has declined 52.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7091 per EA |
|---|---|
| All-time high | $1.4782 (Apr 10, 2024) |
| All-time low | $0.6998 (Nov 19, 2025) |
| 52-week high | $0.7961 |
| 52-week low | $0.6998 |
| Median price | $0.8140 |
| Average price | $0.8839 |
| Largest weekly change | -21.3% (May 22, 2024) |
| Weeks tracked | 124 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the isosorbide dinitrate and hydralazine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET, manufactured by i3 Pharmaceuticals, LLC, is $0.7091 per EA (NDC 72319001203), effective Aug 19, 2026.
How has the price of ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET has declined 52.0%. It has been tracked across 124 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?
Since Apr 10, 2024, the NADAC for ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET has ranged from a low of $0.6998 (Nov 19, 2025) to a high of $1.4782 (Apr 10, 2024), with a median of $0.8140 per EA.
Are there cheaper alternatives to ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET?
ISOSORBIDE-HYDRALAZINE 20-37.5 MG TABLET (NDC 72319001203) is labeled by i3 Pharmaceuticals, LLC, and CMS classifies it as a generic product.